rs1553278844
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024529.5(CDC73):c.376C>T(p.Arg126*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024529.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hyperparathyroidism 2 with jaw tumorsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
- hyperparathyroidism 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- parathyroid gland carcinomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial isolated hyperparathyroidismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Parathyroid carcinoma Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg126*) in the CDC73 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDC73 are known to be pathogenic (PMID: 12434154). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with parathyroid adenoma, jaw tumor, and/or primary hyperparathyroidism (PMID: 23293331; internal data). ClinVar contains an entry for this variant (Variation ID: 462760). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23293331, 29225260, 32590342, 35586626) -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R126* pathogenic mutation (also known as c.376C>T), located in coding exon 5 of the CDC73 gene, results from a C to T substitution at nucleotide position 376. This changes the amino acid from an arginine to a stop codon within coding exon 5. This alteration has been identified in multiple individuals with hyperparathyroidism (Bricaire L et al. J. Clin. Endocrinol. Metab., 2013 Feb;98:E403-8; Koikawa K et al. Intern. Med., 2018 Mar;57:841-844). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at